AGIO vs OKTA · rev $65.5M vs P/E 84, rev $1.57B
Agios Pharm (AGIO) versus Okta Inc (OKTA) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
AGIO currently screens at market cap $1.68B. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Not investment advice. Open the AGIO and OKTA stock pages for the full models.
Not investment advice.